New cell atlas maps aging across tissues and species

Until now, senescent cells (cells that stop dividing and begin secreting harmful signals) were mostly studied one organ or disease model at a time. That made comparisons difficult. The SenNet project, described in Nature Aging, takes a different approach: the researchers collect cellular data from dozens of tissues, in humans and animals, at multiple points across the lifespan.

The goal is a reference atlas: a coherent map showing how many senescent cells exist in which tissues, what molecular signatures they carry, and how that changes with age. Think of it as a geographic map, but for cellular aging across the body.

Multiple organs studied in parallel

The strength of the approach lies in its breadth. By collecting data across tissues, species, and life stages at once, researchers can detect patterns that remain hidden in isolated studies. Is cellular senescence in the kidney the same process as in the brain? Does it unfold differently in mice than in humans? The atlas makes those comparisons possible.

That is scientifically relevant, but also practically important. Many longevity interventions aim to reduce or eliminate senescent cells. But if those cells function differently in each organ, a one-size-fits-all approach is likely too blunt. An atlas can indicate which tissues deserve priority under which strategy.

An ongoing project

The Nature Aging publication describes the collection and methodology, not a final conclusion. The SenNet project is still active. Its current value lies in the infrastructure it provides: standardized data that other research groups can use and build upon. For the longevity field, this is the kind of investment whose returns will come over time, not immediately.

Still, the publication marks a meaningful step. It is the first time cellular senescence has been mapped in such a systematic and coordinated way, across the full breadth of the body and multiple species simultaneously.

Read the original article